ANAB
AnaptysBio Inc
Halal Rating :
Last Price
$15.85
Last updated:
Market Cap
-
7D Change
8.41%
1 Year Change
-33.26%
Company Overview
Industries
Exchange
Next Earnings Date
AnaptysBio Inc is a clinical-stage biotechnology company focused on developing therapeutic antibodies for inflammatory diseases and immune-oncology. The company's main focus is on developing first-in-class antibody product candidates designed to target unmet medical needs in inflammation and immuno-oncology.
The company's pipeline includes several clinical and preclinical stage programs targeting various inflammatory diseases and cancers. Their lead product candidates utilize their proprietary antibody discovery technology platform.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $30.02m | $68.19m | - | $15.41m | 0.00% | 22.60% |
| June 30, 2024 | $10.97m | $62.24m | - | $10.95m | 0.00% | 17.60% |
| March 31, 2024 | $7.18m | $55.7m | - | $6.32m | 0.00% | 11.34% |
Company Impact
Help us evaluate AnaptysBio Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.